These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21168244)

  • 1. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E; Hanauer SB
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL; Miles CJ; Gearry RB
    N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L; Marko C; Breidert M
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    Ruiz-Clavijo D; Arín A; Vila JJ; Albéniz E; Picazo R; Casi M
    An Sist Sanit Navar; 2013 Sep; 36(2):353-6. PubMed ID: 24008542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
    Arnott ID; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
    Laish I; Pomeranz I; Kitay-Cohen Y; Konikof F
    Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D; Decaestecker J; De Wulf D; Ghillebert G; Van Vlierberghe H; Van Dorpe J; Baert F
    Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelotoxicity and hepatotoxicity during azathioprine therapy.
    de Boer NK; Mulder CJ; van Bodegraven AA
    Neth J Med; 2005 Dec; 63(11):444-6. PubMed ID: 16397313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.
    Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB
    Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected azathioprine induced liver cirrhosis: an unusual side effect.
    Trabelsi AB; Hamami E; Souguir A; Ksiaa M; Ajmi S; Jmaa A
    Pan Afr Med J; 2014; 17():174. PubMed ID: 25392720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J; Zech CJ; Diebold J; Schoenberg SO; Brand S; Tillack C; Göke B; Ochsenkühn T
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease].
    Garrido Serrano A; Pérez Martín F; Guerrero Igea FJ; Galbarro Muñoz J; Palomo Gil S
    Gastroenterol Hepatol; 2000 Jan; 23(1):7-8. PubMed ID: 10726375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.